Healthcare >> CEO Interviews >> October 1, 2007

Joseph Cummins – Amarillo Biosciences, Inc. (amar)

TWST: What is Amarillo Biosciences today?

Dr. Cummins: We are a public company developing low-dose oral interferon for use

in animals and humans. Interferon is an approved drug by injection,